T1	Participants 65 121	postmenopausal patients with metastatic breast carcinoma
T2	Participants 212 275	Breast cancer patients with prior response to endocrine therapy
T3	Participants 642 669	683 postmenopausal patients
T4	Participants 1703 1786	postmenopausal patients with metastatic breast carcinoma after one hormonal therapy
